Second Annual Pathology Educational...
Transcript of Second Annual Pathology Educational...
Second Annual Pathology
Educational Symposium
September 29 - October 2, 2014
Turner Auditorium 720 Rutland Avenue
Baltimore, MD 21205
Sponsored by the Department of Pathology
2
Description: This Continuing Education event is intended for all Johns Hopkins Medicine Department of Pathology staff.
Cost: Free to Pathology employees.
Preregistration is encouraged. See your Supervisor to preregister. JHM ID is required for electronic attendance tracking.
Registration: Lower Turner Concourse
Register in person only once on the first day of attendance. Breaks: Light refreshments available between sessions in the Lower Turner Concourse. Lunch: Will be provided for days attendee is preregistered. Pick-up is in the West Room. Monday, September 29 12:15-12:50p Tuesday, September 30 12:00-12:45p Wednesday, October 1 12:00-12:45p Attendance Documentation & Certificate:
1. Swipe ID badge or sign in for all sessions attending 2. Document Session Code on Attendance Documentation
form 3. Turn in completed Attendance Documentation form at
registration desk or email to Symposium Committee. Both sign-in (or swipe-in) and Attendance Documentation form are required to receive your PACE® certificate.
4. Certificate and Evaluations will be emailed to attendee after the Symposium.
Johns Hopkins Medicine is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
3
Monday, September 29, 2014
9a-3:30p: Registration (Turner Concourse) 10:00a-11:00a Room: Tilghman Auditorium
The Journey of a Breast Biopsy: Part 1 Course # 612-108-14 / 1.0 credit hours
Leigh Plomchock, MS, PA(ASCP)CM
Lead Pathologists’ Assistant, Surgical Pathology Laboratory, The Johns Hopkins Hospital
Carolyn Gallagher, HT(ASCP) Histopath Tech II, Surgical Pathology Laboratory, The Johns Hopkins Hospital
Nichelle Gray, BS Clinical Laboratory Coordinator, Immunopathology Laboratory, The Johns Hopkins University School of Medicine
Charlotte Randall-Ramos Specimen Accessioning Coordinator, Surgical Pathology Laboratory, The Johns Hopkins Hospital United States Army, Sgt A.S
Patricia Marsh, BS Consult Coordinator, Surgical Pathology, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Histology/Surgical Pathology Target Audience: All are welcome Description: How does a pathologist make a diagnosis? What areas assist and work in unison to achieve that quick turnaround time to give an accurate result to the patient? Accessioners, pathologist assistants, histotechnologists, the Immunohistochemistry Lab, the Consult Office, the Cytogenetics Lab, and all our support staff understand that the importance of close communication cannot be overemphasized in patient care. Smooth workflow with the concentration on accuracy and quality of the specimen will achieve the correct diagnosis from our pathologists for our patients. Objectives: At the completion of the presentation, the audience will be able to:
Recognize all the areas involved in obtaining a diagnosis of breast cancer
Identify key processing steps of a breast biopsy
4
Monday, September 29, 2014 10:00a-11:00a Room: TBD
Laboratory Diagnosis of Celiac Disease and Gluten-
Related Disorders Course # 612-141-14 / 1.0 credit hours
Daniela Cihakova, MD, PhD, D(ABMLI)
Assistant Professor of Pathology Director, Immune Disorders Laboratory, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Immunology Target Audience: All are welcome Description: Celiac disease (CD) is an autoimmune-mediated inflammation of the small intestine, strongly dependent on HLA-DQ2 and HLA-DQ8 haplotypes characterized by intolerance of dietary gluten present in wheat, rye, and barley. The diagnostic criteria for celiac disease (CD) have remained unchanged for more than 20 years. However, in 2013 the American College of Gastroenterology and independently the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) both published new guidelines for the diagnosis of CD. We will summarize the main changes with the emphasis on laboratory testing in diagnosis of CD. Besides CD, there are other gluten-related disorders, wheat allergy and gluten sensitivity. There is a great interest in gluten sensitivity and its relation to other disorders and overall health. We will discuss which laboratory methods are currently used for diagnosis of gluten sensitivity. Objectives: At the completion of the presentation, the audience will be able to:
Describe new evidence-based guidance for diagnosis of celiac disease
Explain the use of different laboratory tests in diagnosis of celiac disease
Describe the clinical presentation and laboratory findings of other gluten-related disorders
5
Monday, September 29, 2014
11:15a-12:15a Room: Tilghman Auditorium
The Journey of a Breast Biopsy: Part 2 - “Pathology
of the Breast” Course # 612-109-14 / 1.0 credit hours
Pedram Argani, MD Professor of Pathology, Surgical Pathology Laboratory, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Histology/Surgical Pathology Target Audience: All are welcome Description: Breast cancer is the No. 2 cause of cancer in women in the USA. One out of every nine American women will develop breast cancer. This presentation will focus on normal breast tissue, common benign causes of a breast mass or microcalcifications, ductal carcinoma in situ, and invasive ductal carcinoma. Sample cases will also be discussed. Objectives: At the completion of the presentation, the audience will be able to:
Identify the anatomy of the breast
Explain the pathology of the breast
6
Monday, September 29, 2014
11:15a-12:15p: Room: Turner Auditorium
Pathology at Johns Hopkins: A History
Course # 612-101-14 /1.0 credit hour
Edward F. McCarthy, MD Professor of Pathology and Orthopedic Surgery, The Johns Hopkins University School of Medicine
Level of Instructions: Basic Category: General Target Audience: All are welcome Description: Have you ever wondered about the history of Pathology at Johns Hopkins? Join us for the kick-off of the Second Annual Pathology Educational Symposium with a history lesson about the early years of Pathology at Johns Hopkins Medicine. Objectives: At the completion of the presentation, the audience will be able to:
Recall the history of Johns Hopkins Pathology
Identify the various Chairmen in the Department of Pathology
Discuss how the Department of Pathology was founded
7
Monday, September 29, 2014
1:00-2:00p: Room: TBD
Blood Group Family Feud Course # 612-102-14 / 1.0 credit hours
Zachary Bergner, MT(ASCP) Instrument Specialist, Transfusion Medicine, The Johns Hopkins Hospital
Lorraine N. Blagg, MA, MLS(ASCP)CMSBB Education & Development Coordinator, Transfusion Medicine, The Johns Hopkins Hospital
Level of Instruction: Intermediate Category: Immunohematology/Blood Bank Target Audience: Technologists, leads, supervisors, managers, and educators Description: It’s time to play the Feud! This will be an interactive game based on the TV show, Family Feud. Two Blood Group families (Kell and Dombrock) will be pitted against one another to name the most popular responses to survey-type questions about Blood Groups. Our families will be selected from the audience. Objectives: At the completion of the presentation, the audience will be able to:
Participate in an interactive way to review immunohematology facts
Identify antigens and antibodies based on their serologic characteristics
8
Monday, September 29, 2014
1:00-2:00p: Room: TBD
HPV-Related Head and Neck Squamous Cell
Carcinoma Course # 612-127-14 / 1.0 credit hours
Zahra Maleki, MD Assistant Professor of Pathology, Division of Cytopathology, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Cytopathology/Molecular Target Audience: All are welcome Description: This presentation reviews HPV-related head and neck squamous cell carcinoma, including patient demographics, risk factors, anatomic sites, and morphologic findings in cytology and histology specimens. It reviews the role of fine needle aspiration in diagnosis of HPV-related squamous cell carcinoma. It describes the roles of cytotechnologists and cytopathologists in immediate interpretation of the aspirated samples for specimen adequacy. It reviews the molecular studies performed for diagnostic, therapeutic, and prognostic purposes. Finally, it reviews the similarities and differences between HPV-related and non-HPV-related head and neck squamous cell carcinomas. Objectives: At the completion of the presentation, the audience will be able to:
Describe the role of fine needle aspiration in diagnosis of HPV-related head and neck squamous cell carcinoma
Describe the roles of the cytotechnologists and cytopathologists in immediate interpretation of the samples for specimen adequacy
Describe patient demographics, risk factors, anatomic sites, histology and cytology findings, and molecular studies
Describe the similarities and differences between HPV-related and non-HPV-related head and neck squamous cell carcinomas
9
Monday, September 29, 2014
2:15-3:15p: Room: TBD
Contributions of the Laboratory to the Diagnosis of
Human Allergic Disease
Course # 612-120-14 / 1.0 credit hours
Robert G. Hamilton, Ph.D., D.ABMLI Professor of Medicine and Pathology, The Johns Hopkins University School of Medicine
Level of Instruction: Intermediate Category: Immunology Target Audience: All are welcome
Description: Diagnosis of human allergic disease begins with a careful clinical history. Once there is a suspicion of an allergic process, IgE antibody is detected to confirm sensitization and provide guidance on a management strategy. The clinical laboratory continues to play a vital role in facilitating the diagnosis of allergic disease through the quantification of allergen-specific IgE antibody in serum. This overview will discuss the pathophysiology and clinical manifestations of allergic reactions and discuss the serological assays used to quantify IgE antibody to approximately 200 allergen specificities. Component-resolved diagnosis and multiplex technology will be discussed. Objectives: At the completion of the presentation, the audience will be able to:
Identify the pathophysiology of the allergic reaction in humans
Discuss the laboratory methods used to assess a patient for allergic sensitization
Explain the importance of component-resolved diagnosis using individual native and recombinant allergens
Identify how laboratory methods interface with in vivo provocation testing methods in the diagnostic algorithm
10
Monday, September 29, 2014
2:15-3:15p: Room: TBD
Tissue Donation for Transplantation: The People, the
Process and the Success of Allograft Transplants
Course # 612-124-14 / 1.0 credit hours
Rick Kolovich, RN, CPTC, CCTC, CTBS Clinical Manager, Donor Services Living Legacy Foundation
Steven Bell Area Business Manager, Musculoskeletal Transplant Foundation (MTF)
Elizabeth McNamara, RN, MSN Senior Regional Director, Musculoskeletal Transplant Foundation
Level of Instruction: Basic Category: General/ Blood Bank Target Audience: All are welcome
Description: The gift of musculoskeletal tissue (bone) donation after death
has a profound effect annually on thousands of recipients. The gift of bone donation provides individuals with a renewed ability to walk, throw a ball, pick up their grandchildren, return to work and be pain-free while in activity. The gift additionally assists the donor family/significant others as they seek to find solace and a positive outcome from the loss of their loved one. Musculoskeletal donation is a win-win for so many. How can you help? This presentation will discuss the referral/recovery process and bone utilization at Johns Hopkins Medicine. Critical to the process is communication to the Living Legacy Foundation of the potential donor and the hospital course. On the recipient side, the knowledge of the utilization of bone in a variety of forms and procedures and the communication to the allograft recipient of the MTF Linking Lives program is key.
Objectives: At the completion of the presentation, the audience will be able to:
Describe the Living Legacy Foundation’s (LLF) tissue donation process, from referral to recovery
Describe LLF’s primary and secondary screening process of potential donors and the impact on Johns Hopkins Medicine
Describe the significance of allograft utilization at Johns Hopkins Medicine and the positive impact on the recipient lives
11
Monday, September 29, 2014
3:30-4:30p: Room: TBD
Stem Cell Products: What’s in The Bag?
Course # 612-135-14 / 1.0 credit hours
Janice Davis-Sproul, MAS, MT(ASCP)SBB Manager, Cell Therapy Laboratory, The Johns Hopkins University
Angela Ondo, MT(ASCP) BMT/CTL Quality Assurance Manager, Cell Therapy Laboratory, The Johns Hopkins Hospital
Level of Instruction: Basic Category: Cellular Therapy/Blood Bank/Hematology Target Audience: All are welcome
Description: This presentation will discuss hematopoietic stem cell sources, cellular therapy product processing and testing, and the role of quality in the Cell Therapy Laboratory. Objectives: At the completion of the presentation, the audience will be able to:
Identify sources of stem cells
Describe product processing based on the donor and recipient’s ABO type
Discuss product testing (sterility and flow cytometric) and acceptable results
Describe future roles for cell-based therapies in cancer treatments
12
Tuesday, September 30, 2014 8a-3:30p: Registration (Turner Concourse)
8:30a-10:45a Room: Tilghman Auditorium
The Art of Quality Control, Selected Topics Course # 612-118-14 / 2.0 credit hours
Michael Toyoshima, MT(ASCP)SC, CLS Technical Support Advisor, Bio-Rad Laboratories, Irvine, California
Level of Instruction: Intermediate Category: Clinical Chemistry/Hematology/Quality Assurance Target Audience: Technologists, leads, supervisors, managers, and those who use lab results Description: Inappropriate quality control wastes time and resources and may lead to the release of incorrect patient results. Attend this workshop to improve the quality control of your laboratory testing. Through lecture and case studies you will explore the fundamentals and real life applications of quality control, learn what to do about unexpected QC values, and add problem-resolution schemes to your troubleshooting skills. Objectives: At the completion of the presentation, the audience will be able to:
Explain the conditions and steps involved in obtaining a valid QC image
Perform troubleshooting of specific laboratory problems by reviewing reports and applying appropriate QC principles
13
Tuesday, September 30, 2014
8:30a-9:30a Room: TBD
The Next Generation of Cancer Diagnostics: Clinical
Proteomics? Course # 612-114-14 / 1.0 credit hours
Daniel W. Chan, PhD, DABCC, FACB Professor of Pathology, Oncology, Radiology, and Urology Director, Clinical Chemistry Division, and the Center for Biomarker Discovery and Translation, The Johns Hopkins Medical Institutions
Level of Instruction: Basic Category: Clinical Chemistry/Molecular/Research Target Audience: All are welcome Description: The future of tumor markers will likely come from the discoveries of proteomic biomarkers. In this presentation, the research conducted at the Center for Biomarker Discovery and Translation will be described. In addition, pictures will be shown of the advances in the world of proteomic technologies and how they were used to translate ovarian and prostate cancer biomarkers into clinical diagnostics for patient care. Objectives: At the completion of the presentation, the audience will be able to:
Describe tumor markers for clinical application
Describe proteomics technologies
Review the process of biomarker discovery
Explain the process of biomarker translation
14
Tuesday, September 30, 2014
8:30a-9:30a Room: TBD
Emerging and Reemerging Viral Infections Course # 612-129-14 / 1.0 credit hours
Nicole Kwiatkowski, MLS(ASCP)CM
Laboratory Supervisor, Microbiology, The Johns Hopkins Hospital
Level of Instruction: Intermediate Category: Microbiology Target Audience: All are welcome
Description: A review of the ecology, epidemiology, clinical manifestations and diagnostics testing of recently emerging and re-emerging viral pathogens. Objectives: At the completion of the presentation, the audience will be able to:
Describe general viral infective cycles
Categorize viruses in the appropriate genetic class
Describe clinical manifestations, ecology, and epidemiology of the covered emerging viral pathogens
Explain virus-vector-host interactions
15
Tuesday, September 30, 2014
9:45a-10:45a Room: TBD
JHH Response to Shooter Event: Options for
Employees Course # 612-138-14 / 1.0 credit hours
Howard Gwon, MS, CHEC Senior Director, Office of Emergency Management, Johns Hopkins Medicine
Level of Instruction: Basic Category: General/Safety (Emergency Management) Target Audience: All are welcome
Description: Hospitals may be faced with incidents of workplace violence with little or no warning. The Johns Hopkins Medicine Senior Director of Emergency Management will present options for employees on how to respond to an active shooter while on duty. He will also review the Hospital's response procedures in conjunction with these responsibilities. Objectives: At the completion of the presentation, the audience will be able to:
Discuss impact of active shooter incidents in hospitals and healthcare settings
Describe how to respond to an active shooter
Describe how to better protect oneself and others in using the options “run, hide, fight”
16
Tuesday, September 30, 2014
9:45a-10:45a Room: TBD
TB Testing in International Laboratories -- Changes
and Challenges Course # 612-117-14 / 1.0 credit hours
Peggy Coulter, MDE, MT(HEW) Senior International Laboratory QA/QC Coordinator, Patient Safety Monitoring in International Laboratories (SMILE), The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Microbiology/Quality Assurance Target Audience: All are welcome Description: This presentation will show how Tuberculosis (TB) laboratories have changed over the last 10 years in areas where TB prevalence is high. It will also cover some of the challenges that TB laboratories encounter and the measures taken to overcome them. During the presentation, the impact of improvement in biosafety practices, advances in technology, QA/QC, as well as the importance of attitudes will be covered. Objectives: At the completion of the presentation, the audience will be able to:
Describe the significance of Tuberculosis infection worldwide
Identify changes in policy and standards relating to TB laboratories
Explain how biosafety has changed in laboratories in developing countries
Discuss quality indicators and new tuberculosis diagnostic methods
17
Tuesday, September 30, 2014 11:00a-12:00p Room: TBD
Weird Micro, Part Deux: More Interesting Cases
from the Lab Course # 612-103-14 / 1.0 credit hours
Paula Mister, MS, MT(ASCP)SM Educational & Development Coordinator, Clinical Microbiology, The Johns Hopkins Hospital
Level of Instruction: Intermediate Category: Microbiology Target Audience: Technologists, leads, supervisors, managers, physicians Description: Back by popular demand!! Case presentations of unusual pathogenic microorganisms, or pathogens from unexpected body sources, from specimens received in the Johns Hopkins Clinical Microbiology Laboratory. This will be an interactive session, similar to last year, in which clues are given to assist participants in making the correct diagnosis. There will be a brief discussion of methods both new and old, to assist technologists in recognition and identification of these pathogens. Objectives: At the completion of the presentation, the audience will be able to:
Integrate information from patient history, symptoms, lab results, and additional clues to postulate microbiologic pathogens from cases presented
Develop an increased awareness of potentially unusual pathogens and pathogens from unusual sources in the clinical laboratory
Describe laboratory methods that can detect these pathogens in an accurate and timely manner
18
Tuesday, September 30, 2014 11:00a-12:00p Room: TBD
Preventing Disruptive Behavior from Escalating at
Work Course # 612-125-14 / 1.0 credit hours
Errin Britt, JD, PHR Program Manager, Johns Hopkins Workplace Violence Assessment
Level of Instruction: Basic Category: Administrative/HR/Safety Target Audience: All are welcome Description: This module is designed to help employees better understand what disruptive behaviors look like and how to respond when there are concerns. Objectives: At the completion of the presentation, the audience will be able to:
Identify basic facts about disruptive behaviors at work
Review the Johns Hopkins Continuum of Disruptive Behaviors at work
Review how to identify behaviors of concern
Locate resources to help
19
Tuesday, September 30, 2014
11:00a-12:00p Room: TBD
Not Your Typical Blood Bank Case Studies Course # 612-105-14 / 1.0 credit hours
Lorraine N. Blagg, MA, MLS(ASCP)CMSBB Education & Development Coordinator, Transfusion Medicine, The Johns Hopkins Hospital
Level of Instruction: Intermediate Category: Immunohematology/Blood Bank Target Audience: Technologists, leads, supervisors, managers, educators Description: Not all decision-making and problem-solving in the blood bank revolve around antibody identification. This presentation will utilize case studies and your smartphone to answer questions that encompass analysis of serologic results, clinical data, patient history, and technology to resolve problems faced in the blood bank. Objectives: At the completion of the presentation, the audience will be able to:
Analyze serology and patient medical history to resolve unexpected results
Evaluate special methods or technology to address problems presented in the blood bank
Recommend transfusion management based on clinical and serological information
Utilize your smartphone and Poll Everywhere app to answer questions for each case presented (http://www.PollEv.com/bloodbankcases)
20
Tuesday, September 30, 2014
1:00p-3:15p (15 minute break) Room: TBD
The Clinical Laboratory in Sub-Saharan Africa Course # 612-110-14 / 2.0 credit hours
Timothy Amukele, MD, PhD Assistant Professor of Pathology, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Quality Assurance/ Regulatory/ Immunology Target Audience: All are welcome Description: Many people are interested in the state of laboratories in poor countries, but aside from occasional reports of missionaries helping individual hospitals, there isn’t much known. This lecture will summarize much of the research in laboratories in Sub-Saharan Africa, their number and quality, as well as test use and test costs. The conversation will be framed in terms of which interventions serve to improve quality in settings without regulatory oversight. Objectives: At the completion of the presentation, the audience will be able to:
List the number and location of accredited labs in Sub-Saharan Africa (SSA)
Describe the quality of the “best” labs in SSA compared to labs in the West
Identify the factor most strongly associated with high quality of “average” labs
Describe laboratory test use and laboratory test costs in Sub-Saharan Africa
21
Tuesday, September 30, 2014
Time: 1:00p-2:00p Room: TBD
Legal Highs: A Packet and a Patient. What can the
Clinical Laboratory Do? Course # 612-122-14 / 1.0 credit hours
David A. Sartori, PhD Clinical Chemistry Fellow, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Clinical Chemistry Target Audience: All are welcome Description: Bath salts (synthetic cathinones) represent a new and potentially dangerous class of drugs of abuse, involving intoxication that can present as a sympathomimetic toxidrome. Duration and clinical presentation can be complicated by co-ingestion of depressive agents. Clinical testing for these compounds is very difficult and limited to specific reference labs at the moment. A review of the literature and discussion of a clinical case will be presented. Objectives: At the completion of the presentation, the audience will be able to:
Recognize the structural diversity of synthetic cathinones
Discuss of the limitations of clinical testing and potential testing for the future
Identify the diverse clinical presentation and range of effects that users have
22
Tuesday, September 30, 2014
Time: 1:00p-2:00p Room: TBD
Of Plague and Pestilence: A Disease of the Past? Course # 612-130-14 / 1.0 credit hours
Nicholas Boire, ScM Research Technologist, Department of Pathology, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Microbiology Target Audience: All are welcome Description: Plague is one of the most well-known and important diseases in human history. While most people know the “Black Death” that plagued Europe throughout the Middle Ages, fewer know of plague’s existence and relevance today. Despite its apparent absence in our daily life, plague is an important re-emerging infectious disease. This discussion will highlight the history of plague, including its use in bio-warfare; its microbiology (diagnostics, pathogenicity, and treatment); and finally, factors which may contribute to plague possibly becoming what it once was—a pandemic killer. Objectives: At the completion of the presentation, the audience will be able to:
Discuss factors responsible for plague outbreaks
Recall a thorough historical account of plague
Explain clinical and laboratory aspects of plague, including identification, pathology, and treatment
23
Tuesday, September 30, 2014
Time: 2:15p-3:15p Room: Tilghman Auditorium
The Microbiology of Food: James Beard Meets
Typhoid Mary Course # 612-136-14 / 1.0 credit hours
Brandon C. Ellis, MLS(ASCP)CM Supervisor, Microbiology, The Johns Hopkins Hospital
Level of Instruction: Basic Category: Microbiology Target Audience: All are welcome
Description: Microbiology plays an important role in the culinary world, from the mushrooms we eat to the bacteria and fungi used to make cheese, bread, wine, and beer. While these microbes play an integral part in making some of the best food and drinks in the world, others can cause serious foodborne illnesses and death. This presentation includes an introduction to some of the microbiological processes used to produce food, common foodborne illnesses, and food safety. Objectives: At the completion of the presentation, the audience will be able to:
Describe microbiological techniques and processes used to produce cheese, beer, and other food and drinks
Discuss common foodborne illnesses and their impact on the food industry and society
Utilize good food safety practices and culinary tips
24
Tuesday, September 30, 2014
Time: 2:15p-3:15p Room: TBD
Diagnosis & Treatment of Thrombotic
Thrombocytopenic Purpura Course # 612-137-14 / 1.0 credit hours
Jennifer Bynum, MD Resident Physician, Department of Pathology, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Hematology/Blood Bank Target Audience: All are welcome Description: Thrombotic Thrombocytopenic Purpura (TTP) is a rapid onset and potentially fatal disorder in which both clotting and bleeding occur. Unlike most bleeding in thrombocytopenic patients, platelet transfusions are contraindicated. We will discuss causes, signs and symptoms, laboratory testing, and treatment options. Objectives: At the completion of the presentation, the audience will be able to:
Describe the pathophysiology of TTP
Identify laboratory tests that aid in diagnosis and treatment monitoring of TTP
Recommend treatment options
Discuss the use of different replacement fluids in plasma exchange
25
Tuesday, September 30, 2014
Time: 3:30p-4:30p Room: Tilghman Auditorium
Safety of Today’s Plasma-Derived Products Course # 612-139-14 / 1.0 credit hours
Paula Ulsh, RN, BSN Senior Medical Science Liaison, Hemostasis, Kedrion Biopharma Inc.
Level of Instruction: Basic Category: Blood Bank/Hematology Target Audience: All are welcome
Description: Presentation on the safety of today's human source plasma products including understanding the past history and the industry response for improved an safety profile, Plasma Protein Therapeutic Association (PPTA) Industry Standards, and the Seven Safety Steps built into the manufacturing process from donor plasma collection to final product. Objectives: At the completion of the presentation, the audience will be able to:
Recall the past history of human source plasma products, risk identification, and the industry’s response for an improved safety profile
Identify the Plasma Protein Therapeutic Association (PPTA) Industry Guidelines
Identify the Seven Safety Steps built into the manufacturing process from donor plasma collection to final human source product and pharmacovigilence monitoring
26
Wednesday, October 1, 2014
8a-3:30p: Registration (Turner Concourse) 8:30a-9:30a Room: Tilghman Auditorium
Hematology Hodgepodge Course # 612-119-14 / 1.0 credit hours
Michael Tushek, MT(ASCP)SH Clinical Laboratory Scientist III, Howard County General Hospital
Level of Instruction: Intermediate Category: Hematology Target Audience: Technologists, leads, supervisors, managers, educators Description: There will be six to eight case studies presented from various areas of hematology to include coagulation, parasitology, hemoglobinopathies, and leukemias. Objectives: At the completion of the presentation, the audience will be able to:
Develop the ability to use multiple disciplines to come up with a diagnosis in an unusual or rare disease state
Interpret laboratory results and associate them with a differential diagnosis
27
Wednesday, October 1, 2014
8:30a-9:30a Room: Miller Research Building (MRB) G01
Best Practices in Phlebotomy Course # 612-142-14 / 1.0 credit hours
Charles Andrews Jr., PBT (ASCP) PACE Business Analyst, Johns Hopkins Healthcare
Level of Instruction: Basic Category: Phlebotomy Target Audience: Phlebotomists, technologists, leads, supervisors, managers, nurses, physicians
Description: Phlebotomists are the face of the clinical laboratory because they are the primary interaction patients have with their laboratory results. Phlebotomy skill is not only drawing blood for testing, but involves interacting and answering patient questions, and ensuring that the right specimen from the right patient is drawn at the right time. Objectives: At the completion of the presentation, the audience will be able to:
Identify the role of the phlebotomist in the process of diagnosis and/or treating patients
Explain the importance of proper patient identification
Prepare to respond to patient questions during phlebotomy
28
Wednesday, October 1, 2014
8:30a-10:45a Room: Turner Auditorium
The Art of Quality Control, Selected Topics (Repeat presentation)
Course # 612-118-14 / 2.0 credit hours
Michael Toyoshima, MT(ASCP)SC, CLS Technical Support Advisor, Bio-Rad Laboratories, Irvine, California
Level of Instruction: Intermediate Category: Clinical Chemistry/Hematology/Quality Assurance Target Audience: Technologists, leads, supervisors, managers, those who use lab results Description: Inappropriate quality control wastes time and resources and may lead to the release of incorrect patient results. Attend this workshop to improve the quality control of your laboratory testing. Through lecture and case studies you will explore the fundamentals and real life applications of quality control, learn what to do about unexpected QC values, and add problem-resolution schemes to your troubleshooting skills. Objectives: At the completion of the presentation, the audience will be able to:
Explain the conditions and steps involved to obtain a valid QC image
Perform troubleshooting of specific laboratory problems by reviewing reports and applying appropriate QC principles
29
Wednesday, October 1, 2014 9:45a-10:45a Room: Tilghman Auditorium
Meeting Meaningful Use Stage 2: A Focus from the
Laboratory Course # 612-107-14 / 1.0 credit hours
P. Michael Huppenthal, MBA, MT(ASCP) Pathology Project Administrator, The Johns Hopkins Hospital
Level of Instruction: Basic Category: Computer/IT Target Audience: All are welcome Description: A new federal government incentive program has been developed that rewards healthcare providers and organizations who invest in Electronic Health Records (EHR) technology. The incentives are based on how the provider or organization is “meaningfully using the EHR.” This presentation will focus on describing the objectives of meeting meaningful use and how workflow at the lab bench impacts key measures. Objectives: At the completion of the presentation, the audience will be able to:
Explain the basics of Meaningful Use
Describe Core, Menu, and Quality Measures
Review lab-specific measures and identify how we meet the objectives
Report on how The Johns Hopkins Hospital is doing since the July 1 attestation
30
Wednesday, October 1, 2014
9:45a-10:45a Room: Miller Research Building (MRB) G01
Role of Fine Needle Aspiration in Head and Neck
Mass Lesions Course # 612-126-14 / 1.0 credit hours
Zahra Maleki, MD Assistant Professor of Pathology, Cytopathology Division, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Cytopathology Target Audience: All are welcome Description: This presentation reviews the fine needle aspiration procedure and its advantage in head and neck lesions. It describes the roles of cytotechnologists and cytopathologists in immediate interpretation of specimens and specimen triage. It reviews the main categories of head and neck lesions including congenital, infectious and neoplastic with a review of thyroid, salivary gland, lymph node, and a few miscellaneous lesions. Finally, it reviews the role of cytology in treatment and prognosis of malignant neoplasms in head and neck lesions with emphasis on ancillary studies, e.g., immunohistochemistry and molecular studies. Objectives: At the completion of the presentation, the audience will be able to:
Describe the fine needle aspiration procedure and its advantage
Describe the roles of cytotechnologists and cytopathologists in immediate interpretation of specimens of specimen triage
Recognize main categories of head and neck lesions including congenital, infectious, and neoplastic, with examples of multiple organs
Describe the role of cytology in diagnosis, treatment, and prognosis of neoplastic lesions using ancillary studies such as immunohistochemistry and molecular studies
31
Wednesday, October 1, 2014
11:00a-12:00p Room: TBD
Know Your Team Course # 612-140-14 / 1.0 credit hours
Anita Morris-Hopkins Laboratory Support Services Supervisor, Surgical Pathology Lab, The Johns Hopkins Hospital
Level of Instruction: Basic Category: General Target Audience: All are welcome Description: This presentation is designed to help supervisors better know the people they are leading. Attendees will learn how to build relationships that can make a difference between an employee staying or leaving. In this discussion attendees will learn how to create an environment of trust in which the team feels motivated to meet goals and contribute to the success of the department. Your team will recognize your genuine efforts to get to know their perspectives and contributions. Objectives: At the completion of the presentation, the audience will be able to:
Explain how to improve your work environment
Identify two helpful ways to better know your team
Formulate a way to increase your accuracy of perception, to become a better observer
Demonstrate how to work with people who have different styles
32
Wednesday, October 1, 2014
11:00a-12:00p Room: TBD
Common Brain and Eye Specimens and Disease Course # 612-115-14 / 1.0 credit hours
Charles G. Eberhart, MD, PhD Professor of Pathology, Director of Neuropathology and Ophthalmic Pathology, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Histology/Surgical Pathology Target Audience: All are welcome Description: Overview of the specimens which commonly come from ophthalmologists and neurosurgeons, including discussion of how to process them and common diagnoses. Objectives: At the completion of the presentation, the audience will be able to:
Discuss issues which can arise when processing ophthalmic specimens
Discuss issues which can arise when processing neurosurgical specimens
33
Wednesday, October 1, 2014
11:00a-12:00p Room: TBD
Antimicrobial Susceptibility Testing: What is the True
Clinical Value? Course # 612-131-14 / 1.0 credit hours
Stefan Riedel, MD, PhD, D(ABMM) Director, Clinical Pathology Laboratory, The Johns Hopkins Bayview Medical Center
Level of Instruction: Intermediate Category: Microbiology Target Audience: Technologists, leads, supervisors, managers, nurses, physicians, physician assistants Description: This presentation will discuss various methods used for antimicrobial susceptibility testing and the interpretive guidelines used when applying these methods. The final discussion will include aspects of clinical utility and impact on patient care. Objectives: At the completion of the presentation, the audience will be able to:
Describe the various methods used for antimicrobial susceptibility testing (AST)
Describe the principles of interpretive guidelines for AST
Describe the limitations of AST
Describe the clinical utility and implications for patient care
34
Wednesday, October 1, 2014
1:00p-2:00p Room: Tilghman Auditorium
Next Generation Sequencing Course # 612-113-14 / 1.0 credit hours
James R. Eshleman, MD, PhD Professor of Pathology, Department of Pathology, The Johns Hopkins University School of Medicine
Level of Instruction: Intermediate Category: Molecular Target Audience: All are welcome Description: Next Generation DNA Sequencing (NGS) has revolutionized biomedical discovery. For example, in the next few years all gene mutations for all the cancers will be known. The impact of NGS on clinical molecular diagnostics will explode in the next decade. Objectives: At the completion of the presentation, the audience will be able to:
Explain the basic methods of Next Generation Sequencing
Appreciate the impact Next Generation Sequencing will have on clinical testing
35
Wednesday, October 1, 2014
1:00p-2:00p Room: TBD
Inspection Readiness
Course # 612-128-14 / 1.0 credit hours
Barbara Parsons, MA, MT(ASCP) Assistant Director, Quality Management, Pathology Department, Johns Hopkins Medicine
Deborah Williams, MT(ASCP) Laboratory Quality Assurance Coordinator, Suburban Hospital
Jeanne Mumford, MT(ASCP) Laboratory Quality Assurance Specialist, Johns Hopkins Community Physicians
Level of Instruction: Basic Category: Quality Assurance Target Audience: All are welcome Description: Clinical laboratories must submit to an unannounced inspection
by federal or designated accreditation body inspectors at least every two years. These inspections are complete and systematic evaluations to determine a laboratory's ability to provide accurate and reliable results. Laboratories must be "inspection ready" at all times to conform with regulatory requirements, as well as to continually ensure quality and safe patient care. This session will provide participants with methods and tools to maintain ongoing readiness in various types of laboratories. How to address laboratory staff engagement in the readiness process will be included.
Objectives: At the completion of the presentation, the audience will be able to:
Describe how ongoing inspection readiness will help you prepare for an unannounced on-site inspection
Compare what inspection readiness means to different types of laboratories
Explain the importance of laboratory staff participation in the inspection readiness process
Describe how inspection ready methods and tools will help improve laboratory quality and promote continuous compliance with regulatory requirements
36
Wednesday, October 1, 2014
1:00p-2:00p Room: Miller Research Building (MRB) G01
Innovation: Thinking Outside the Box (Limit 40 attendees) Course # 612-123-14 / 1.0 credit hours
Megeen Thomas Administrative Coordinator, Department of Learning & Development, Talent Management and Organization Development, The Johns Hopkins University
Julia Jorczak Talent Management Consultant, Talent Management and Organization Development, The Johns Hopkins University
Level of Instruction: Basic Category: General Target Audience: Limited to Pathology staff only Description: No doubt about it -- we live and work in an environment that is constantly changing. As a result, we are called upon to become more flexible, creative, adaptable, and resilient than ever before. During this session, you will learn to amplify your innate ability to be creative and innovative, which will help you manage both your personal and professional challenges. Objectives: At the completion of the presentation, the audience will be able to:
Define what it means to be innovative
Identify characteristics of innovative individuals and teams
Identify and address your personal blocks to being innovative
Explore various “creativity boosters” to help you and your team apply innovative approaches and solutions
37
Wednesday, October 1, 2014
2:15p-3:15p Room: Turner Auditorium
Social Media Liability for Health Care Practitioners
and Staff Course # 612-112-14 / 1.0 credit hours
Jeffrey Natterman, RRT, MA, JD Risk Manager, The Johns Hopkins Hospital Associate Senior Counsel, Johns Hopkins Health System
Level of Instruction: Basic Category: Legal/Safety Target Audience: All are welcome Description: With the universality of communication technology and social media, health care workers are at increased risk of exposure to civil, criminal, and administrative liability for failure to follow regulations and specific duties. The cost to staff can be in the form of monetary damages, criminal sanctions, and licensure-related penalties. The law is complex, but over the years has become clearer with each subsequent generation of communication technology and case law. Objectives: At the completion of the presentation, the audience will be able to:
Identify important social media case law updates
Recognize when liability for a breach of duty would attach
Explain the updates to legislation involving the electronic communications paradigm
38
Wednesday, October 1, 2014
2:15p-3:15p Room: Tilghman Auditorium
Drug-Resistant Mycobacteria: The Current State of
Diagnostics Course # 612-132-14 / 1.0 credit hours
Nicole Parrish, PhD, MHS, D(ABMM) Assistant Professor of Pathology Director of Medical Mycobacteriology, The Johns Hopkins Hospital
Level of Instruction: Intermediate Category: Microbiology Target Audience: All are welcome Description: The talk will focus on the emergence of antibiotic resistance in the mycobacteria, including slow-growing and rapid-growing species as well as M. tuberculosis. Clinical cases will be used to illustrate particular examples. Specific attention will be paid to emerging issues with regard to antibiotic susceptibility testing and detection of resistance. Objectives: At the completion of the presentation, the audience will be able to:
Discuss emerging resistance in mycobacteria
Describe drug susceptibility testing and emerging issues
39
Wednesday, October 1, 2014
3:30-4:30p Room: Tilghman Auditorium
Pathology’s Role in Patient- and Family-Centered
Care Course # 612-106-14 / 1.0 credit hours
Christine M. Hostetter, MA, MT(ASCP) Education & Staff Development Coordinator, Core and Specialty Laboratories, The Johns Hopkins Hospital
Level of Instruction: Basic Category: General Target Audience: All are welcome Description: Johns Hopkins Medicine’s Strategic Plan includes a patient- and family-centered care priority. This presentation and group discussion will illuminate ways that Pathology is already participating in this strategy and will explore new initiatives to be an integral part of JHM’s aim to “Be the National Leader in the Safety, Science, Teaching and Provision of Patient- and Family-Centered Care.” Objectives: At the completion of the presentation, the audience will be able to:
Summarize the patient- and family-centered care movement throughout the United States and adopted by Johns Hopkins Medicine and pathology professional societies
Recognize, celebrate, and promote everyday patient- and family-centered activities in the Pathology workplace
Plan and initiate new opportunities to strengthen the bond between Pathology employees and patients and their families
40
Thursday, October 2, 2014
7:30a-11:30a: Registration (Turner Concourse) 8:00a-9:00a Room: TBD
Repurposing and Other Thrifty Shades of Green Course # 612-104-14 / 1.0 credit hours
Karen Wittler, HT(ASCP) Histology Tech II, Anatomic Pathology, The Johns Hopkins Hospital
Level of Instruction: Basic Category: General and Safety Target Audience: All are welcome Description: The journey continues…. A clever repurposing project was largely responsible for the Histology Lab’s attainment of The Johns Hopkins Hospital’s 2013 Sustainability Award for “The Greenest Department.” We will retrace our path from NSH workshop, “Green Histology,” to the award, with an emphasis on taking responsibility for more difficult challenges that we face. We must reduce exposure to hazardous materials to ensure a safer work environment, which is a darker shade of Going Green. The 2014 JHH Greenest Department Contest is underway and the entries are remarkable! Prepare to share in the cost-saving and environmentally-friendly measures taken by our rivals, but Histology’s entry will be Top Secret until September. Objectives: At the completion of the presentation, the audience will be able to:
Demonstrate how new information can be implemented and have surprising results
Discuss the challenges of getting everyone to “buy in” to a Green Initiative
Utilize JHH resources that are available to assist you in “greening” your workplace
Create a safer work environment by reducing exposure to hazardous materials
41
Thursday, October 2, 2014
8:00a-9:00a Room: TBD
Best Practices in Phlebotomy (Repeat presentation)
Course # 612-142-14 / 1.0 credit hours
Charles Andrews Jr., PBT (ASCP) PACE Business Analyst, Johns Hopkins Healthcare
Level of Instruction: Basic Category: Phlebotomy Target Audience: Phlebotomists, technologists, leads, supervisors, managers, nurses, physicians
Description: Phlebotomists are the face of the clinical laboratory because they are the primary interaction patients have with their laboratory results. Phlebotomy skill is not only drawing blood for testing, but involves interacting and answering patient questions, and ensuring that the right specimen from the right patient is drawn at the right time. Objectives: At the completion of the presentation, the audience will be able to:
Identify the role of the phlebotomist in the process of diagnosis and/or treating patients
Explain the importance of proper patient identification
Prepare to respond to patient questions during phlebotomy
42
Thursday, October 2, 2014
9:15a-10:15a Room: TBD
Therapeutic Plasma Exchange in Kidney Transplant
Recipients at The Johns Hopkins Hospital Course # 612-121-14 / 1.0 credit hours
Andrea McGonigle, MD Transfusion Medicine Fellow, The Johns Hopkins University School of Medicine
Level of Instruction: Intermediate Category: Immunohematology/Blood Bank Target Audience: Technologists, leads, supervisors, managers, educators, nurses, physicians, physician assistants, transfusionists
Description: Therapeutic plasma exchange (TPE) can reduce high-titer antibodies which are responsible for humoral rejection in kidney and other solid organ transplants. This technique is particularly useful in ABO-mismatched transplantation, where it can be used to lower the peritransplant antibody titer to prevent hyperacute rejection and improve graft survival. TPE also plays a similar role in reducing HLA antibodies prior to and following kidney transplantation. Following transplantation, if antibody titers increase or clinical and histologic signs of humoral rejection arise, TPE can then be used as an effective adjunct therapy. Objectives: At the completion of the presentation, the audience will be able to:
Describe the therapeutic plasma exchange program for ABO-mismatched kidney transplant recipients at JHH
Describe the role of therapeutic plasma exchange in reducing HLA antibodies in kidney transplant recipients at JHH
Describe the use of therapeutic plasma exchange as an adjunct therapy for humoral rejection in kidney transplant
43
Thursday, October 2, 2014
9:15a-10:15a Room: TBD
Basics of Lean Improvement Explained Course # 612-133-14 / 1.0 credit hours
Richard Hill, CLSBB Senior Quality and Innovation Coach, Johns Hopkins Medicine
Level of Instruction: Basic Category: Quality Assurance Target Audience: All are welcome Description: Lean methodology is used to help health care organizations improve quality and reduce costs. It can be applied to virtually any system where waste exists. Attend this session with a quality/innovations coach from the Armstrong Institute to answer the following questions: What is Lean? What is waste? How does waste impact my life? What can I do about it? Examples of waste present at home and at work will be discussed. Objectives: At the completion of the presentation, the audience will be able to:
Identify the various forms of waste that can be reduced/eliminated
Describe how waste can be seen
Discover and apply simple tools to fix the waste
44
Thursday, October 2, 2014
10:30a-11:30a Room: TBD
Diabetes: Testing, Diagnosis, and Management Course # 612-116-14 / 1.0 credit hours
Chris Crutchfield, PhD Clinical Chemistry Fellow, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Clinical Chemistry Target Audience: Technologists, technicians, and all are welcome Description: Diabetes has had a major impact on the American public. Over one million adults are diagnosed annually. These individuals may have heard about diabetes or have a family member with it, but may not understand how to interpret the tests their doctor orders for them, or how the management of their disease impacts their wellbeing. This lecture will give an overview of the development of diabetes, the laboratory tests that are ordered for a patient with diabetes, and how these tests directly inform the management of the disease. Objectives: At the completion of the presentation, the audience will be able to:
Describe the differences between Type I and Type II diabetes
Explain how different lab tests are used for the diagnosis and management of diabetes
Discuss the consequences of untreated diabetes
Review different strategies for improving the outcomes of patients with diabetes
45
Thursday, October 2, 2014
10:30a-11:30a Room: TBD
Combatting Negativity in the Workplace Course # 612-134-14 / 1.0 credit hours
Alissa Putman, PhD Director, FASAP, The Johns Hopkins University
Level of Instruction: Basic Category: General Target Audience: All are welcome Description: “Negative attitudes spread to the point where they eventually affect performance and decision-making. That's the bad news. The good news is that enthusiasm and positive attitudes spread just as quickly and affect performance just as much -- in the right direction.” (Dale Carnegie). There are several factors which contribute to negativity, including maladaptive thoughts, increased stress, increased conflict and decreased support. The presence of negativity in the workplace is on the rise and adversely affects work performance, relationships, and ultimately patient care. This workshop will detail factors that contribute to negativity in the workplace, as well as ways to combat them to ensure a more positive work environment. Topics covered will include: identifying and stopping maladaptive thoughts, learning stress management and conflict management techniques, preventing burnout and compassion fatigue, and building resiliency. Objectives: At the completion of the presentation, the audience will be able to:
Identify six factors that contribute to negativity in the workplace
Identify positive actions that can be taken to combat negativity and to help with being more productive at work
Identify and stop maladaptive thought patterns that cause negativity in the workplace
Identify the meaning of stress, burnout and compassion fatigue and learn ways to reduce each
State 10 ways to build resilience
46
Thursday, October 2, 2014
Closing Session
11:45a-12:45p Room: Turner Auditorium
Pathology and the Choosing Wisely® Campaign:
Claiming our Role in Guiding Safer and More Cost-
Effective Test Utilization
Course # 612-111-14 / 1.0 credit hours
Genevieve M. Crane, MD, PhD Resident Physician, PGY2, Department of Pathology, The Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Phlebotomy/Safety Target Audience: All are welcome
Description: The Choosing Wisely® campaign is a nationally-led campaign
initiated by the American Board of Internal Medicine with the goal of promoting conversations between physicians and patients to better utilize limited resources for health care. Over 40 national medical organizations, including the ASCP, have released lists of five things that should be questioned and may be overused or inappropriately used. At Johns Hopkins Medicine, the resident-led House Staff Patient Quality Council is spearheading an initiative based on this campaign to streamline test utilization to improve both quality and effectiveness of patient care while reducing costs within the system. Pathology should play a key role both in the optimization of tests and in the education of both physicians and patients on when tests are best indicated. Objectives: At the completion of the presentation, the audience will be able to:
List the goals of the nationwide Choosing Wisely® Campaign
Explain the importance of improving physician and patient understanding of medical tests and their efficacy
Identify areas of test overuse that may benefit from closer analysis of potential benefit in specific clinical contexts
Evaluate the evidence demonstrating clinical utility, safety and cost- effectiveness of tests to order them more wisely
Advise patients who may want (or not want) a test based on expectations outside of evidence-based criteria
47
Second Annual Pathology
Educational Symposium Schedule at a Glance
Key:
General Chemistry Computer
Surgical Pathology Hematology Molecular
Blood Bank Microbiology Quality Assurance
Cytology Immunology Phlebotomy
Pathology Symposium Committee Chair: Barbara Parsons & Lorraine Blagg
Barbara Detrick Mayer Rubin Christine Hostetter Meredith Hurston Cynthia Jordan Nancy Nath Debbie Williams Paula Mister Doris Pendergrass Renata Karlos Eun Hee Cho Rosemary Hines Eunhee Rim Sandra Thacker Jo Shim Suzy Nicol Karen Bordenet Tammy Heacock Kurt Michael Vanessa Rodas-Eral Marian Turpin
48
Lun
ch
(We
st Ro
om
)
Ro
om
#2
Ro
om
#1
Hu
rd H
all
Re
gistra
tion
(Low
er Tu
rne
r Co
nc
ou
rse)
Mo
nd
ay
Se
pte
mb
er 2
9, 2
01
4
Pa
tho
log
y
Gra
nd
Ro
un
ds
8:3
0 A
M
Re
gistra
tion
9a
-3:3
0p
Ce
liac
Dise
ase
an
d
Glu
ten
-
rela
ted
diso
rde
rs
Jo
urn
ey
of a
Bre
ast
Bio
psy
Pa
rt 1
10
:00
AM
Histo
ry o
f
Jo
hn
s
Ho
pk
ins
Pa
tho
log
y
Jo
urn
ey
of a
Bre
ast
Bio
psy
Pa
rt 2
11
:15
AM
Lun
ch
12
:15
PM
HPV
-Re
late
d
He
ad
& N
ec
k
squ
am
ou
s
Ce
ll
Ca
rcin
om
a
Blo
od
Gro
up
Fa
mily
Fe
ud
1:0
0 P
M
Lab
ora
tory
in D
iag
no
sis
of H
um
an
Alle
rgic
Dise
ase
Tissue
Do
na
tion
for
Tran
spla
nta
tion
2:1
5 P
M
Ste
m C
ell
Pro
du
cts:
Wh
at’s in
the
Ba
g?
3:3
0 P
M
Se
co
nd
An
nu
al P
ath
olo
gy
Ed
uc
atio
na
l Sy
mp
osiu
m
Sc
he
du
le a
t a G
lan
ce
Se
co
nd
An
nu
al P
ath
olo
gy
Ed
uc
atio
na
l Sy
mp
osiu
m
Sc
he
du
le a
t a G
lan
ce
49
Lun
ch
(We
st Ro
om
)
Ro
om
#3
Ro
om
#2
Ro
om
#1
Re
gistra
tion
(Lo
we
r Turn
er C
on
co
urse
)
Tue
sda
y
Se
pte
mb
er 3
0, 2
01
4
Re
gistra
tion
8a
-3:3
0p
8:0
0
AM
The
Art o
f Qu
ality
(40
pe
rson
min
imu
m)
2 h
rs
Em
erg
ing
an
d R
e-
em
erg
ing
Vira
l
Infe
ctio
ns
Ne
xt
Ge
ne
ratio
n o
f
Ca
nc
er
Dia
gn
ostic
s:
Clin
ica
l
Pro
teo
mic
s
8:3
0 A
M
TB Te
sting
in
Inte
rna
tion
al
Lab
ora
torie
s
Re
spo
nse
to S
ho
ote
r
Ev
en
t
9:4
5 A
M
No
t Yo
ur
Typ
ica
l Blo
od
Ba
nk
Ca
se
Stu
die
s
We
ird
Mic
ro, P
art
De
ux
Pre
ve
nt
Disru
ptiv
e
Be
ha
vio
rs
from
Esc
ala
ting
at W
ork
11
:00
AM
Lun
ch
12
:00
PM
Clin
ica
l Lab
ora
tory
in S
ub
-
Sa
ha
ran
Afric
a
2 h
rs
Of P
lag
ue
an
d
Pe
stilen
ce
Leg
al H
igh
:
A P
ac
ke
t
an
d a
Pa
tien
t
1:0
0 P
M
Mic
rob
iolo
gy
Of F
oo
d
Dia
gn
osis &
Trea
tme
nt o
f
TTP
2:1
5 P
M
Sa
fety
of
Tod
ay
’s
Pla
sma
De
rive
d
Pro
du
cts
3:3
0 P
M
Se
co
nd
An
nu
al P
ath
olo
gy
Ed
uc
atio
na
l Sy
mp
osiu
m
Sc
he
du
le a
t a G
lan
ce
50
Lun
ch
(We
st Ro
om
)
Ro
om
#3
Ro
om
#2
Ro
om
#1
Re
gistra
tion
(Lo
we
r Turn
er C
on
co
urse
)
We
dn
esd
ay
Oc
tob
er 1
, 20
14
Re
gistra
tion
8a
-3:3
0p
8:0
0
AM
The
Art o
f Qu
ality
Co
ntro
l
(40
pe
rson
min
imu
m)
2 h
rs
Be
st
Pra
ctic
es in
Ph
leb
oto
my
He
ma
tolo
gy
Ho
dg
eP
od
ge
8:3
0 A
M
Ro
le o
f Fin
e
Ne
ed
le
Asp
iratio
n in
He
ad
& N
ec
k
Ma
ss Lesio
ns
Me
etin
g
Me
an
ing
ful U
se
Sta
ge
2: A
Fo
cu
s from
the
Lab
ora
tory
9:4
5 A
M
An
timic
rob
ial
Su
sce
ptib
ility
Testin
g:
Co
mm
on
Bra
in a
nd
Ey
e
Sp
ec
ime
ns
& D
isea
se
Kn
ow
Yo
ur
Tea
m
11
:00
AM
Lun
ch
12
:00
PM
Insp
ec
tion
Re
ad
ine
ss
Ne
xt
Ge
ne
ratio
n
Se
qu
en
cin
g
Inn
ov
atio
n:
Thin
kin
g
Ou
tside
The
Bo
x
(Limit 2
5)
1:0
0 P
M
Dru
g
Re
sistan
t
Mycobacte
ria
So
cia
l Me
dia
Liab
ility fo
r
He
alth
Ca
re
Pra
ctitio
ne
rs
2:1
5 P
M
Pa
tho
log
y’s
Ro
le in
Pa
tien
t &
Fa
mily
Ce
nte
red
Ca
re
3:3
0 P
M
Se
co
nd
An
nu
al P
ath
olo
gy
Ed
uc
atio
na
l Sy
mp
osiu
m
Sc
he
du
le a
t a G
lan
ce
51
Ro
om
#2
Ro
om
#1
Re
gistra
tion
(Low
er Tu
rne
r Co
nc
ou
rse)
Thu
rsda
y
Oc
tob
er 2
, 20
14
Re
gistra
tion
7:3
0a
-11:4
5p
7:3
0
AM
Be
st Pra
ctic
es in
Ph
leb
oto
my
Re
pu
rpo
sing
an
d
Oth
er Th
rifty
Sh
ad
es o
f Gre
en
8:0
0 A
M
The
rap
eu
tic
Pla
sma
Ex
ch
an
ge
in K
idn
ey
Tran
spla
nt
Re
cip
ien
ts
Ba
sics o
f LEA
N
imp
rov
em
en
t
ex
pla
ine
d
9:1
5 A
M
Co
mb
attin
g
Ne
ga
tivity
in th
e
Wo
rkp
lac
e
Dia
be
tes: Te
sting
,
Dia
gn
osis, &
Ma
na
ge
me
nt
10
:30
AM
Pa
tho
log
y a
nd
the
Ch
oo
sing
Wise
ly®
Ca
mp
aig
n
11
:45
PM
Se
co
nd
An
nu
al P
ath
olo
gy
Ed
uc
atio
na
l Sy
mp
osiu
m
Sc
he
du
le a
t a G
lan
ce
Se
co
nd
An
nu
al P
ath
olo
gy
Ed
uc
atio
na
l Sy
mp
osiu
m
Sc
he
du
le a
t a G
lan
ce
52
REGISTRATION
Name: _____________________________ Badge #:___________________ Email: ________________________________________________________ JHM Entity: ________________ Division: ___________________________ Supervisor/Manager: ___________________________________________
Selection for the Sessions: Employee: This is a preliminary schedule and is subject to change. To aid us in planning and assigning rooms for each talk, please mark the sessions that you would like to attend. Registration deadline is Thursday, September 11, 2014. Fill out and submit to your Supervisor for approval. Are you interested in Volunteering for this event? Yes No Please visit to select volunteer opportunity : http://vols.pt/mhpovk Supervisor: After approving registrations for your staff, each employee will need to be registered no later than Tuesday, September 16, 2014, at https://www.surveymonkey.com/s/registration2ndpathologysymposium. MONDAY, SEPTEMBER 29, 2014 Time Course
10:00-11:00a 612-141-14, Celiac Disease & Gluten-Related Disorders 10:00-11:00a 612-108-14, Journey of a Breast Biopsy: Part 1 11:15-12:15p 612-109-14, Journey of a Breast Biopsy: Part 2 11:15-12:15p 612-101-14, Pathology at Johns Hopkins: A History 1:00-2:00p 612-102-14, Blood Group Family Feud 1:00-2:00p 612-127-14, HPV-Related Head and Neck Squamous Cell Carcinoma 2:15-3:15p 612-120-14, Laboratory Dx of Human Allergic Disease 2:15-3:15p 612-124-14, Tissue Donation for Transplantation 3:30-4:30p 612-135-14, Stem Cell Products: What’s in the Bag? TUESDAY, SEPTEMBER 30, 2014 Time Course
8:30-9:30a 612-114-14, Next Generation of Cancer Diagnostics: Clinical Proteomics? 8:30-9:30a 612-129-14, Emerging and Re-emerging Viral Infections 8:30-10:45a 612-118-14, Art of Quality Control 9:45-10:45a 612-117-14, TB Testing in International Laboratories 9:45-10:45a 612-138-14, JHH Response to Shooter Event
53
REGISTRATION (continued) TUESDAY, SEPTEMBER 30, 2014 (continued) Time Course
11:00-12:00p 612-103-14, Weird Micro, Part Deux 11:00-12:00p 612-125-14, Preventing Disruptive Behavior 11:00-12:00p 612-105-14, Not Your Typical Blood Bank Case Studies 1:00-2:00p 612-122-14, Legal Highs: A Packet and a Patient 1:00-2:00p 612-130-14, Of Plague and Pestilence 1:00 – 3:15p 612-110-14, Clinical Laboratory in Sub-Saharan Africa 2:15-3:15p 612-136-14, Microbiology of Food 2:15-3:15p 612-137-14, Diagnosis & Treatment of TTP 3:30-4:30p 612-139-14, Safety of Today’s Plasma Derived Products
WEDNESDAY, OCTOBER 1, 2014 Time Course
8:30-9:30a 612-119-14, Hematology Hodgepodge 8:30-9:30a 612-142-14, Best Practices in Phlebotomy 8:30-10:45a 612-118-14, Art of Quality Control 9:45-10:45a 612-107-14, Meeting Meaningful Use Stage 2 9:45-10:45a 612-126-14, Fine Needle Aspiration of Head & Neck 11:00-12:00p 612-140-14, Know Your Team 11:00-12:00p 612-115-14, Common Brain & Eye Specimens & Disease 11:00-12:00p 612-131-14, Antimicrobial Susceptibility Testing 1:00-2:00p 612-113-14, Next Generation Sequencing 1:00-2:00p 612-128-14, Inspection Readiness 1:00-2:00p 612-123-14, Innovation: Thinking Outside the Box(Limited) 2:15-3:15p 612-112-14, Social Media Liability for Health Care 2:15-3:15p 612-132-14, Drug-Resistant Mycobacteria 3:30-4:30p 612-106-14, Pathology’s Role in Patient- and Family- Centered Care THURSDAY, OCTOBER 2, 2014 Time Course
8:00-9:00a 612-104-14, Repurposing & Thrifty Shades of Green 8:00-9:00a 612-142-14, Best Practices in Phlebotomy 9:15-10:15a 612-121-14, Therapeutic Plasma Exchange in Kidney Transplant Recipients 9:15-10:15a 612-133-14, Basics of Lean Improvement Explained 10:30-11:30a 612-116-14, Diabetes: Testing, Dx, & Management 10:30-11:30a 612-134-14, Combatting Negativity in Workplace 11:45-12:45p 612-111-14, Pathology & Choosing Wisely® Campaign